The goal of this clinical trial is to evaluate the clinical efficacy of an antimicrobial mouthrinse, with a particular focus on its effect on established plaque and the improvement of gum health.
Participants will:
* Brush and rinse twice a day with the designated products for 6 months * Visit the clinic once every 3 months after baseline for reassessment.
Male and female subjects aged 18-70 years, inclusive.
Availability for the 6-month duration of the clinical research study.
Good general health based on the opinion of the study investigator.
Signed Informed Consent Form.
Be under orthodontic treatment.
Presence of partial removable dentures.
Tumor(s) of the soft or hard tissues of the oral cavity.
Participants with current moderate or severe periodontitis (periodontitis screening index [PSI] >2 in more than 2 sextants or PSI >3), and/or purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone.